Healthcare / Medical Care FacilitiesThailand
$1.44
+0.00 (+0.00%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 23% · confianza 25%
FCF escenarios
weak_data · normalized FCF $985.5M · quality 81.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
42/100
C
Piotroski
6/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$15.8B
P/E
16.0x
↓EV/EBITDA
8.4x
↓ROE
11.9%
↑Gross Margin
28.4%
↓Debt/Equity
0.07
↓TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
-6.2%
FCF CAGR
-18.3%
FCF margin
11.8%
FCF / Net income
1.06x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $8.35B · net income $929.4M · FCF $985.5M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $8.35B | $8.35B | $8.24B | $7.73B | $10.10B |
| Net Income | $929.4M | $929.4M | $965.2M | $1.05B | $2.78B |
| EBITDA | $1.76B | $1.76B | $1.78B | $1.81B | $3.95B |
| EPS | 0.08 | 0.08 | 0.09 | 0.10 | 0.25 |
| Gross Margin | 28.4% | 28.4% | 26.3% | 27.2% | 41.5% |
| Operating Margin | 15.0% | 15.0% | 15.6% | 17.9% | 35.3% |
| Net Margin | 11.1% | 11.1% | 11.7% | 13.5% | 27.5% |
| Balance Sheet | |||||
| Debt/Equity | 0.07 | 0.07 | 0.09 | 0.10 | 0.12 |
| Current Ratio | 2.97 | 2.97 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $985.5M | $985.5M | $1.13B | $979.8M | $1.81B |
| Returns | |||||
| ROE | 11.9% | 11.9% | 12.5% | 13.9% | 36.9% |
| Valuation | |||||
| P/E | 16.00 | 16.00 | 27.99 | 30.84 | 14.62 |
| EV/EBITDA | 8.35 | 8.35 | 14.64 | 17.46 | 10.01 |
| P/B | 2.03 | 2.03 | 3.50 | 4.29 | 5.41 |
| Growth & Yield | |||||
| Revenue Growth | 1.3% | 1.3% | 6.6% | -23.5% | — |
| EPS Growth | -3.6% | -3.6% | -7.8% | -62.4% | — |
| Dividend Yield | 5.0% | 5.0% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
14.8%
EPS terminal req.
$0.13
Spread vs growth
-18.4%
5Y implied EPS CAGR
12.8%
EPS terminal req.
$0.15
Spread vs growth
-16.5%
10Y implied EPS CAGR
11.4%
EPS terminal req.
$0.25
Spread vs growth
-15.1%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-15.4%
Start / end P/E
20.1x → 16.6x
EPS bridge
0.09 → 0.08
Residual
+0.6%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.